secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acrivon Therapeutics, Inc. (ACRV)
CIK:        0001781174
Form:       8-K
Filed at:   2022-11-17T23:59:59+00:00
Accession:  0001193125-22-287727
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.02, 8.01, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acrivon Therapeutics completes IPO and concurrent $5M private placement with Chione Limited
--------------------------------------------------------------------------------

- Closed IPO and concurrent $5M private placement with Chione Limited on Nov 17, 2022.
- Issued 400,000 unregistered shares at $12.50/share to Chione under Section 4(a)(2) exemption.
- Filed amended certificate of incorporation and bylaws effective upon IPO closing.
- Shares in private placement are subject to lock-up and transfer restrictions; no public offering registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1781174/000119312522287727/0001193125-22-287727-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1781174/000119312522287727/d410573d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-287727

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer